Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia.

Abstract	The results in this study confirm and expand previous reports that ischemia-modified albumin (IMA) is an early marker of ischemia in the setting of percutaneous coronary intervention (PCI). We observed that IMA levels are related to the number of inflations, inflation pressure, and duration of inflations. It is therefore likely that IMA reflects the magnitude and duration of ischemia induced during PCI.
Authors	Juan Quiles, Debashis Roy, David Gaze, Iris Paula Garrido, Pablo Avanzas, Manas Sinha, Juan Carlos Kaski
Journal	The American journal of cardiology (Am J Cardiol) Vol. 92 Issue 3 Pg. 322-4 (Aug 01 2003) ISSN: 0002-9149 [Print] United States
PMID	12888145 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Biomarkers Serum Albumin
Topics	Angina Pectoris (therapy) Angioplasty, Balloon, Coronary (adverse effects, methods) Biomarkers (blood) Elective Surgical Procedures (adverse effects) Female Humans Male Middle Aged Myocardial Ischemia (blood, etiology) Serum Albumin (metabolism) Time

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!